entertainment -WSS

entertainment

author：knowledge 2025-09-30 17:29:07 - browse：488

Sammy Kimball for STAT

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.

For more on what we cover, here’s the latest on Merck; here’s more from ASCO; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How to save PrEP access — and even expand it
Next article： Senators tussle over abortion against the backdrop of a presidential campaign

WSS

How AI helped researchers track recovery from depression

Stopping antidepressants leads to symptoms for 1 in 6 patients

FDA panel to weigh approval of NurOwn, controversial ALS drug

How AI helped researchers track recovery from depression

Elevance PBM president out as customers face prescription chaos

Finland to offer bird flu vaccine to select groups of people, a possible global first

leisure time

entertainment

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

The most pressing bird flu mysteries scientists want answered

Bright Health sells Medicare Advantage business to Molina

FTC loses bid to block Novant's North Carolina hospital merger

Wildfire smoke exposes gaps in outdoor worker protections

Lasker Awards 2023: Winners in biomedical research

23andMe had bad news about my health. I wish a person had delivered it

Data don't support strong claims for Covid

The cancer drug shortage isn’t new — and neither are the solutions

The most pressing bird flu mysteries scientists want answered

focus

Eli Lilly’s Zepbound improved liver scarring in mid

Intarcia’s device

Finland to offer bird flu vaccine to select groups of people, a possible global first

CMS got Medicare Advantage quality rating wrong, judge rules

Thermo Fisher plant for manufacturing gene therapies to expand

ASCO Takeaways: Winners, snoozers, and the art of cancer care

hotspot

hotspot

entertainment

focus